Feeling Safe (Sentirnos Seguros) psychological programme for people with schizophrenia and persecutory delusions
Official title: Feeling Safe: Feasibility and Acceptability Study Evaluating a New Psychological Intervention for People With Psychosis and Positive Delusional Symptoms
Run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · NCT07234708 · Data updated 2026-11-12
This pilot will try the Sentirnos Seguros (Feeling Safe) therapy with adults who have schizophrenia-spectrum disorders and persecutory delusions to see if they find it acceptable and experience clinical and functional improvement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 35 (estimated) |
| Sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Academic / other |
| Locations | 1 site (Barcelona) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | March 1, 2028 |
| Study ends | May 1, 2028 |
| Registry record updated | November 21, 2025 |
| Trial ID | NCT07234708 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with a DSM-5 schizophrenia-spectrum or other psychotic disorder who currently have persecutory delusions (PANSS delusions ≥4 and conviction >60%) are the intended participants.
✕Probably not a fit
People with intellectual disability, those with a primary DSM-5 diagnosis other than schizophrenia-spectrum psychosis (except substance-related disorders), or those without prominent persecutory delusions are unlikely to benefit from this programme.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, non-randomised feasibility pilot using a before-and-after design to measure acceptability, satisfaction, clinical outcomes, functional change, and safety following the Sentirnos Seguros intervention. Adults with DSM-5 schizophrenia-spectrum or other psychotic disorders who score ≥4 on the PANSS delusions item and report persecutory beliefs with >60% conviction are enrolled at Hospital Santa Creu i Sant Pau in Barcelona. Participants receive the Sentirnos Seguros psychological programme and are assessed before and after treatment on acceptability, satisfaction, symptom scales, functional measures, and safety. There is no control group; the primary aim is to establish feasibility and preliminary signals of benefit to inform larger controlled trials.
Why it matters
Potential benefit: If successful, the programme could provide an acceptable, culturally adapted psychological option that reduces persecutory delusions and improves daily functioning for patients.
How similar studies have gone: The original Feeling Safe programme has demonstrated benefits for persecutory delusions in prior controlled trials, so this study adapts and tests an approach with existing positive evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women aged 18 years and older * Diagnosis of schizophrenia spectrum disorders and other psychotic disorders according to DSM-5 * Score ≥ 4 on the delusions item of the Positive and Negative Syndrome Scale (PANSS) * Presence of ideas of persecution with a degree of conviction \> 60% in the last 3 months Exclusion Criteria: * Presence of intellectual disability * Meet DSM-5 criteria for other mental health disorders, except for substance-related and addictive disorders
Where it's running
-
Department of Psychiatry. Hospital Santa Creu i Sant Pau
Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Eva Grasa, PhD Psychologist
- Email: egrasa@santpau.cat
- Phone: +34 93 553 78 40
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using non‑wearable sensors to detect sleep‑disordered breathing in hospitalized people with schizophrenia
This project tests whether non‑wearable sleep sensors can detect obstructive sleep apnea and whether apnea is linked to changes in symptoms for hospitalized people with schizophrenia.
-
Improving heart health in Norwegians with severe mental illness
This trial will test whether a 6‑month program of dietary counseling and regular exercise can lower estimated heart disease risk in adults with schizophrenia-spectrum or bipolar I disorder who are overweight and on antipsychotic medication or lithium.
-
Tirzepatide's effects on alcohol intake in patients with schizophrenia and alcohol use disorder
This study is testing if the medication tirzepatide can help people with schizophrenia and alcohol use disorder drink less alcohol over six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.